july newsletter out, page-3

good spot weightlifter and a great newsletter imo.

It maps out nicely what has been occurring and what to expect over the next 6-9 months.

We have:

- the AOD program which has "attracted commercial interest"

- a final decision on the first product category for phusion labs to be announced in the coming weeks

- the "botox" like platinum elixia range being developed

- dermatology and cosmetic development agreements that could become commercial early 2011.

- oxycodyne development advancing with current study completion in Q3.

- insulin put on the back burner to save money and focus on oxycodyne (i'd assume the required funds would come once commercial deals are inked here)

- 6 new Le Metier products to be launched in September

All in all a very nice and well explained roadmap.